Literature DB >> 12151971

Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.

Frederic Gagnadoux1, Cecile Roiron, Emmanuelle Carrie, Laurence Monnier-Cholley, Bernard Lebeau.   

Abstract

A 60-year-old woman with a history of unresectable colon adenocarcinoma was treated by chemotherapy with a combination of oxaliplatin with leucovorin and fluorouracil. Progressive dyspnea and bilateral pulmonary interstitial infiltrates developed. Bronchoscopy with bronchoalveolar lavage confirmed pulmonary eosinophilia. Clinical and radiologic aspects of eosinophilic lung disease cleared after cessation of this combination of chemotherapy and did not recur after reintroduction of leucovorin/fluorouracil alone, suggesting that oxaliplatin was the causative agent. Care was taken to rule out other possible causes for eosinophilic pneumonia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12151971     DOI: 10.1097/00000421-200208000-00014

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  18 in total

1.  Pulmonary toxicity of 5-fluoracil and oxaliplatin.

Authors:  A Ruiz-Casado; M D García; M A Racionero
Journal:  Clin Transl Oncol       Date:  2006-08       Impact factor: 3.405

2.  Interstitial pneumonitis after oxaliplatin treatment in colorectal cancer.

Authors:  Xavier Hernández Yagüe; Ester Soy; Bernardo Queralt Merino; Josep Puig; Miguel Beltrán Fabregat; Ramón Colomer
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

3.  Fatal interstitial pneumonia associated with oxaliplatin-based therapy in a patient with metastatic rectal cancer.

Authors:  Satoshi Ishizone; Naohiko Koide; Noriyuki Akita; Fumitoshi Karasawa; Nobumitsu Kobayashi; Tomonobu Koizumi; Shinichi Miyagawa
Journal:  Clin J Gastroenterol       Date:  2011-03-24

4.  Interstitial pneumonia arising in a patient treated with oxaliplatin, 5-fluorouracil, and, leucovorin (FOLFOX).

Authors:  Katsuki Muneoka; Yoshio Shirai; Masataka Sasaki; Toshifumi Wakai; Jun Sakata; Katsuyoshi Hatakeyama
Journal:  Int J Clin Oncol       Date:  2009-10-25       Impact factor: 3.402

5.  Fatal pneumonitis induced by oxaliplatin.

Authors:  Sara Arévalo Lobera; Naiara Sagastibeltza Mariñelarena; Ibone Elejoste Echeberría; Mireia Melé Olivé; Larraitz Egaña Otaño; Laura Basterretxea Badiola; Adelaida La Casta Muñoa; Mikel Azkue Gabilondo
Journal:  Clin Transl Oncol       Date:  2008-11       Impact factor: 3.405

6.  Oxaliplatin-induced lung injury with allergic reaction.

Authors:  Tetsuya Homma; Masatsugu Kurokawa; Yoshitaka Yamamoto; Satoshi Matsukura; Koushi Ieki; Shintaro Suzuki; Miho Odaka; Shin Watanabe; Munehiro Yamaguchi; Mitsuru Adachi
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

7.  Oxaliplatin-induced lung fibrosis.

Authors:  Arpan Shah; Zarir F Udwadia; Sachin Almel
Journal:  Indian J Med Paediatr Oncol       Date:  2009-07

8.  Oxaliplatin-induced Pulmonary Fibrosis: Two Case Reports.

Authors:  Chun-Geun Ryu; Eun-Joo Jung; Gangmi Kim; Su Ran Kim; Dae-Yong Hwang
Journal:  J Korean Soc Coloproctol       Date:  2011-10-31

9.  Fatal pneumonitis induced by oxaliplatin: description of three cases.

Authors:  L B Pontes; D P D Armentano; A Soares; R C Gansl
Journal:  Case Rep Oncol       Date:  2012-02-29

10.  Granulomatous lung disease requiring mechanical ventilation induced by a single application of oxaliplatin-based chemotherapy for colorectal cancer: a case report.

Authors:  Dane Wildner; Frank Boxberger; Axel Wein; Kerstin Wolff; Heinz Albrecht; Gudrun Männlein; Rolf Janka; Kerstin Amann; Jürgen Siebler; Werner Hohenberger; Markus F Neurath; Richard Strauß
Journal:  Case Rep Oncol Med       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.